Old Web
English
Sign In
Acemap
>
Paper
>
Nivolumab First-Line Therapy for Elderly, Frail Hodgkin Lymphoma Patients: Niviniho, a Lysa Phase II Study
Nivolumab First-Line Therapy for Elderly, Frail Hodgkin Lymphoma Patients: Niviniho, a Lysa Phase II Study
2021
Julien Lazarovici
Sandy Amorim
Krimo Bouabdallah
Stéphanie Guidez
Lysiane Molina
Franck Morschhauser
Anne-Claire Gac
Thomas Gastinne
Kamel Laribi
Vincent Launay
Bohrane Slama
Nawel Belmecheri
Rene-Olivier Casasnovas
Anne Corby
Éric Durot
Pierre Feugier
Emmanuelle Nicolas-Virelizier
David Sibon
Alina Berriolo-Riedinger
Véronique Edeline
Thierry Vander Borght
Diane Damotte
Alexandra Traverse-Glehen
Marc Andre
Vincent Ribrag
Keywords:
frail elderly
hodgkin lymphoma
Medicine
Internal medicine
Oncology
Nivolumab
first line therapy
Phases of clinical research
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]